Acurx Pharmaceuticals announces 1-for-20 reverse stock split effective August 4, 2025 to regain Nasdaq compliance

Acurx Pharmaceuticals, Inc.

Reverse split ratio 1-for-20; effective 4:01 p.m. ET on August 4, 2025.
Post-split trading begins August 5, 2025 under ticker ACXP; new CUSIP 00510M 203.
Outstanding shares reduced from ~30.8M to ~1.5M; authorized shares unchanged.
Fractional shares paid in cash based on August 1, 2025 closing price.
Split approved by stockholders at July 17, 2025 annual meeting; intended to regain Nasdaq minimum bid price compliance.

item 3.03item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.